Report Description:

Global Markets Directs, Avaxia Biologics, Inc. Product Pipeline Review 2015, provides an overview of the Avaxia Biologics, Inc.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Avaxia Biologics, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Browse Full Report with Toc Visit:

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Browse All Reports Of This Category:

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Latest Reports by Acute Market Reports:


  • The report provides brief overview of Avaxia Biologics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Avaxia Biologics, Inc.s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Avaxia Biologics, Inc.s pipeline products

Latest Reports: Avaxia Biologics, Inc. Market to 2015 by Acute Market Reports

Click Here To Download Detail Report:

Reasons to buy:

  • Evaluate Avaxia Biologics, Inc.s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Avaxia Biologics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Avaxia Biologics, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Avaxia Biologics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Avaxia Biologics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Avaxia Biologics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents 2

List of Tables 3

List of Figures 3

Avaxia Biologics, Inc. Snapshot 4

Avaxia Biologics, Inc. Overview 4

Key Information 4

Key Facts 4

Avaxia Biologics, Inc. – Research and Development Overview 5

Key Therapeutic Areas 5

Avaxia Biologics, Inc. – Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products – Monotherapy 8

Avaxia Biologics, Inc. – Pipeline Products Glance 9

Avaxia Biologics, Inc. – Clinical Stage Pipeline Products 9

Phase I Products/Combination Treatment Modalities 9

Avaxia Biologics, Inc. – Early Stage Pipeline Products 10

Preclinical Products/Combination Treatment Modalities 10

Discovery Products/Combination Treatment Modalities 11

Avaxia Biologics, Inc. – Drug Profiles 12

AVX-470 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

AVX-176 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

Antibody for Obesity and Type II Diabetes 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

Avaxia Biologics, Inc. – Pipeline Analysis 15

Avaxia Biologics, Inc. – Pipeline Products by Target 15

Avaxia Biologics, Inc. – Pipeline Products by Route of Administration 16

Avaxia Biologics, Inc. – Pipeline Products by Molecule Type 17

Avaxia Biologics, Inc. – Pipeline Products by Mechanism of Action 18

Avaxia Biologics, Inc. – Recent Pipeline Updates 19

Avaxia Biologics, Inc. – Locations And Subsidiaries 21

Head Office 21

All Reports Of This Publisher:

About Acute Market Reports:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.  We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Contact Us:
Chris Paul
Sales Manager
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Web: AcuteMarketReports